[Hiring] Real World Evidence Lead Endo-Metabolic @Chiesi Group

Role Description

This is what you will do:

• Reporting to the VP, RWE, the Real World Evidence Lead Endocrine-Metabolic (Endo-Met) is responsible for leading and executing the global RWE strategy and vision for the Endo-Met Portfolio within GRD.
• The role ensures the strategy, creation and updating of the integrated evidence generation plan (IEGP), in alignment with cross-functional partners to meet research and commercial objectives.
• The role drives enterprise-level RWE impact, including building strategic data partnerships, advancing innovative methodologies, and influencing cross-functional decision-making.

You will be responsible for:

• RWE Strategy & Leadership:
  • Act as a change agent, effectively communicating the value of RWE and influencing adoption of new processes and approaches.
  • Lead the global RWE strategy for the Endo-Met GRD portfolio, acting as the strategic RWE leader across development, regulatory, and commercialization phases.
  • Ensure integration into regulatory, payer, and clinical decision-making across the Endo-Metabolic Portfolio including Myalepta® (metreleptin) in Lipodystrophy, Juxtapid® / Lojuxta® (lomitapide) in Homozygous Familial Hypercholesterolemia (HoFH) and future pipeline or acquired assets.
  • Increase the integration of RWD sources to enhance evidence-based decision making through research programs.
  • Publish, where appropriate in high impact journals.
• Capability Building & Organizational Leadership:
  • Continuously improve RWE capabilities, processes, and infrastructure to support global and local evidence generation for HIDO.
  • Build and scale RWE capabilities as a competitive advantage for GRD.
  • Establish best practices, standards, and ways of working across regions.
  • Lead change management to embed RWE into core organizational processes.
• External Data & Partnership Strategy:
  • Lead identification, evaluation, and execution of external RWD partnerships and data acquisition strategies.
  • Oversee due diligence, contracting support, and governance of external data sources and collaborations.
  • Build long-term strategic relationships with academic institutions, data vendors, consortia, and healthcare systems.
• Scientific & Technical Leadership:
  • Foster the appropriate use and adoption of appropriate analytic technologies to improve RWE reliability and applicability.
  • Provide senior scientific leadership and deep technical expertise in observational research, epidemiology, and RWE methodologies.
  • Guide study design, analytics strategy, and interpretation of evidence.
  • Ensure adoption of innovative approaches, including AI/ML and advanced analytics, in RWE generation.
• Cross-Functional Influence & Integration:
  • Act as the RWE subject matter expert within cross-functional teams (Medical, Clinical Development, Market Access, Regulatory).
  • Influence asset strategies, development plans, and access strategies.
  • Lead alignment of RWE priorities across global and regional stakeholders.
• Evidence Generation Oversight:
  • Provide executive oversight of RWE studies, registries, and non-interventional programs.
  • Ensure studies are aligned to strategic priorities and deliver high-impact outcomes.
  • Maintain governance of study concept development and prioritization.
• External Scientific Leadership & Visibility:
  • Represent Chiesi externally in scientific forums, consortia, and partnerships.
  • Drive publication strategy and dissemination of RWE insights.
  • Maintain awareness of emerging trends, regulatory guidance, and methodological advances.
• Leadership & Matrix Management:
  • Lead cross-functional and multidisciplinary teams in a matrix environment.
  • Oversee budgets, timelines, and resource allocation across RWE initiatives.
  • Manage consultants, mentor junior team members and as needed, direct reports over time.

Qualifications

• Advanced degree (PhD, DrPH, MD, PharmD, MSc) in epidemiology, public health, health economics, or related field.
• 8+ years of experience in RWE, HEOR, epidemiology, or observational research in pharma/biotech or related setting.
• Demonstrated success in leading RWE strategy at asset or portfolio level.
• Strong experience in real-world data sources (claims, EHR, registries, etc.).
• Proven track record of building partnerships and influencing senior stakeholders.
• Experience supporting regulatory and/or market access use of RWE.
• Deep expertise in epidemiology and RWE methodologies.
• Ability to translate evidence into business and clinical impact.
• Demonstrated ability to influence senior stakeholders and cross-functional leadership.
• Strong executive communication skills.
• Experience with advanced analytics, AI/ML, and innovative RWE approaches.
• Ability to shape data strategy and infrastructure decisions.
• Strong governance and oversight of complex, multi-country studies and programs.
• Ability to manage competing priorities and large-scale initiatives.

Requirements

• Rare disease experience strongly preferred.

Benefits

• The minimum salary for this role is €81.121, aligned to our established salary framework.
• This role is eligible to participate in an annual bonus scheme, subject to company and individual performance.
• Comprehensive benefits package including pension, private medical insurance, wellbeing programme, flexible benefits programme.

Location

• The role can be based in one of our affiliates in Europe, with an estimated 20% of travel requirement, including international travel.

What we offer

No matter where your path starts at Chiesi, it leads to inspiring possibilities. Your future is our focus, and we are committed to nurturing your development in our dynamic, friendly environment with access to resources and training every step of the way.

• Top-class benefits, including comprehensive healthcare programs, work-life balance initiatives, and robust relocation support.
• Competitive salary package, comprising a basic salary, performance bonuses, and benefits benchmarked against the external market.
• Flexible working arrangements, remote work options, and tax assistance services for foreign colleagues.